"breast cancer survivor" trang 11 - tải miễn phí từ tailieunhanh
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
9    36    1
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    52    1
Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer
21    100    1
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients

The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients
11    84    1
Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells

Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells
13    64    1
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
8    64    1
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99
9    49    1
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes

Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes
13    51    1
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: A retrospective study of 164 cases during a 10-year period (2004–2014)

The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: A retrospective study of 164 cases during a 10-year period (2004–2014)
11    60    1
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
15    33    1
CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
12    69    1
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
15    35    1
Serum irisin levels are lower in patients with breast cancer: Association with disease diagnosis and tumor characteristics

Serum irisin levels are lower in patients with breast cancer: Association with disease diagnosis and tumor characteristics
9    32    1
A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer

A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer
10    61    1
Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016

Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016
13    35    1
Effects of payer status on breast cancer survival: A retrospective study

Effects of payer status on breast cancer survival: A retrospective study
8    32    1
Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer

Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
9    28    1
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients

Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients
9    26    1
Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden

Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden
8    41    1
Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach

Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach
10    43    1